Corticosteroid

Revision as of 12:27, 24 May 2025 by imported>OAbot (Open access bot: url-access updated in citation with #oabot.)
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Template:Short description Template:Infobox drug class Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones. Two main classes of corticosteroids, glucocorticoids and mineralocorticoids, are involved in a wide range of physiological processes, including stress response, immune response, and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior.<ref name=NusseySaffron2001>Template:Cite book</ref>

Some common naturally occurring steroid hormones are cortisol (Template:Chem), corticosterone (Template:Chem), cortisone (Template:Chem) and aldosterone (Template:Chem) (cortisone and aldosterone are isomers). The main corticosteroids produced by the adrenal cortex are cortisol and aldosterone.<ref name=NusseySaffron2001 />

The etymology of the cortico- part of the name refers to the adrenal cortex, which makes these steroid hormones. Thus a corticosteroid is a "cortex steroid".Template:Citation needed

Template:TOC limit

ClassesEdit

[[Image:Template:Wikidata|thumb|200px|class=skin-invert-image|Cortisol]] [[Image:Template:Wikidata|thumb|200px|class=skin-invert-image|Cortisone]] [[Image:Template:Wikidata|thumb|200px|class=skin-invert-image|Corticosterone]] [[Image:Template:Wikidata|thumb|200px|class=skin-invert-image|Aldosterone]]

Medical usesEdit

Synthetic pharmaceutical drugs with corticosteroid-like effects are used in a variety of conditions, ranging from hematological neoplasms<ref>Template:Cite journal</ref> to brain tumors or skin diseases. Dexamethasone and its derivatives are almost pure glucocorticoids, while prednisone and its derivatives have some mineralocorticoid action in addition to the glucocorticoid effect. Fludrocortisone (Florinef) is a synthetic mineralocorticoid. Hydrocortisone (cortisol) is typically used for replacement therapy, e.g. for adrenal insufficiency and congenital adrenal hyperplasia.Template:Cn

Medical conditions treated with systemic corticosteroids:<ref name=":1" /><ref>Template:Cite journal</ref>

Template:Div col

Template:Div col end

Topical formulations are also available for the skin, eyes (uveitis), lungs (asthma), nose (rhinitis), and bowels. Corticosteroids are also used supportively to prevent nausea, often in combination with 5-HT3 antagonists (e.g., ondansetron).Template:Cn

Typical undesired effects of glucocorticoids present quite uniformly as drug-induced Cushing's syndrome. Typical mineralocorticoid side-effects are hypertension (abnormally high blood pressure), steroid induced diabetes mellitus, psychosis, poor sleep, hypokalemia (low potassium levels in the blood), hypernatremia (high sodium levels in the blood) without causing peripheral edema, metabolic alkalosis and connective tissue weakness.<ref>Template:Cite book</ref> Wound healing or ulcer formation may be inhibited by the immunosuppressive effects.

A variety of steroid medications, from anti-allergy nasal sprays (Nasonex, Flonase) to topical skin creams, to eye drops (Tobradex), to prednisone have been implicated in the development of central serous retinopathy (CSR).<ref>Template:Cite journal</ref><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

Corticosteroids have been widely used in treating people with traumatic brain injury.<ref>Template:Cite book</ref> A systematic review identified 20 randomised controlled trials and included 12,303 participants, then compared patients who received corticosteroids with patients who received no treatment. The authors recommended people with traumatic head injury should not be routinely treated with corticosteroids.<ref>Template:Cite journal</ref>

PharmacologyEdit

Corticosteroids act as agonists of the glucocorticoid receptor and/or the mineralocorticoid receptor.Template:Cn

In addition to their corticosteroid activity, some corticosteroids may have some progestogenic activity and may produce sex-related side effects.<ref name="pmid10518812">Template:Cite journal</ref><ref name="pmid27874912">Template:Cite journal</ref><ref name="pmid7121132">Template:Cite journal</ref><ref name="pmid376542">Template:Cite journal</ref>

PharmacogeneticsEdit

AsthmaEdit

Patients' response to inhaled corticosteroids has some basis in genetic variations. Two genes of interest are CHRH1 (corticotropin-releasing hormone receptor 1) and TBX21 (transcription factor T-bet). Both genes display some degree of polymorphic variation in humans, which may explain how some patients respond better to inhaled corticosteroid therapy than others.<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref> However, not all asthma patients respond to corticosteroids and large sub groups of asthma patients are corticosteroid resistant.<ref>Template:Cite journal</ref>

A study funded by the Patient-Centered Outcomes Research Institute of children and teens with mild persistent asthma found that using the control inhaler as needed worked the same as daily use in improving asthma control, number of asthma flares, how well the lungs work, and quality of life. Children and teens using the inhaler as needed used about one-fourth the amount of corticosteroid medicine as children and teens using it daily.<ref>Template:Cite journal</ref><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

Adverse effectsEdit

File:Results of topical steroid damage on skin of a 47 year old female.png
Lower arm of a 47-year-old female showing skin damage caused by topical corticosteroid use.

Use of corticosteroids has numerous side-effects, some of which may be severe:

|CitationClass=web }}</ref> and anxiety,<ref>Template:Cite journal</ref> depression. Therapeutic doses may cause a feeling of artificial well-being ("steroid euphoria").<ref>Template:Cite journal</ref> The neuropsychiatric effects are partly mediated by sensitization of the body to the actions of adrenaline. Therapeutically, the bulk of corticosteroid dose is given in the morning to mimic the body's diurnal rhythm; if given at night, the feeling of being energized will interfere with sleep. An extensive review is provided by Flores and Gumina.<ref>Benjamin H. Flores and Heather Kenna Gumina. The Neuropsychiatric Sequelae of Steroid Treatment. URL:http://www.dianafoundation.com/articles/df_04_article_01_steroids_pg01.html</ref>

  • Cardiovascular: Corticosteroids can cause sodium retention through a direct action on the kidney, in a manner analogous to the mineralocorticoid aldosterone. This can result in fluid retention and hypertension.
  • Metabolic: Corticosteroids cause a movement of body fat to the face and torso, resulting in "moon face", "buffalo hump", and "pot belly" or "beer belly", and cause movement of body fat away from the limbs. This has been termed corticosteroid-induced lipodystrophy. Due to the diversion of amino-acids to glucose, they are considered anti-anabolic, and long term therapy can cause muscle wasting (muscle atrophy).<ref>Template:Cite journal</ref> Besides muscle atrophy, steroid myopathy includes muscle pains (myalgias), muscle weakness (typically of the proximal muscles), serum creatine kinase normal, EMG myopathic, and some have type II (fast-twitch/glycolytic) fibre atrophy.<ref>Template:Cite journal</ref>
  • Endocrine: By increasing the production of glucose from amino-acid breakdown and opposing the action of insulin, corticosteroids can cause hyperglycemia,<ref>Template:Cite journal</ref> insulin resistance and diabetes mellitus.<ref>Template:Cite journal</ref>
  • Skeletal: Steroid-induced osteoporosis may be a side-effect of long-term corticosteroid use.<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref><ref>Template:Cite journal</ref> Use of inhaled corticosteroids among children with asthma may result in decreased height.<ref>Template:Cite journal</ref>
  • Gastro-intestinal: While cases of colitis have been reported, corticosteroids are often prescribed when the colitis, although due to suppression of the immune response to pathogens, should be considered only after ruling out infection or microbe/fungal overgrowth in the gastrointestinal tract. While the evidence for corticosteroids causing peptic ulceration is relatively poor except for high doses taken for over a month,<ref name="pmid8826575">Template:Cite journal</ref> the majority of doctors Template:As of still believe this is the case, and would consider protective prophylactic measures.<ref name="pmid20569095">Template:Cite journal</ref>
  • Eyes: chronic use may predispose to cataract and glaucoma. Clinical and experimental evidence indicates that corticosteroids can cause permanent eye damage by inducing central serous retinopathy (CSR, also known as central serous chorioretinopathy, CSC).<ref>Template:Cite journal</ref> This should be borne in mind when treating patients with optic neuritis. There is experimental and clinical evidence that, at least in optic neuritis speed of treatment initiation is important.<ref>Template:Cite journal</ref>
  • Vulnerability to infection: By suppressing immune reactions (which is one of the main reasons for their use in allergies), steroids may cause infections to flare up, notably candidiasis.<ref name="pmid12839324">Template:Cite journal</ref>
  • Pregnancy: Corticosteroids have a low but significant teratogenic effect, causing a few birth defects per 1,000 pregnant women treated. Corticosteroids are therefore contraindicated in pregnancy.<ref name="Shepard-2002">Template:Cite journal</ref>
  • Habituation: Topical steroid addiction (TSA) or red burning skin has been reported in long-term users of topical steroids (users who applied topical steroids to their skin over a period of weeks, months, or years).<ref>Template:Cite journal</ref><ref name="pmid22837556">Template:Cite journal</ref> TSA is characterised by uncontrollable, spreading dermatitis and worsening skin inflammation which requires a stronger topical steroid to get the same result as the first prescription. When topical steroid medication is lost, the skin experiences redness, burning, itching, hot skin, swelling, and/or oozing for a length of time. This is also called 'red skin syndrome' or 'topical steroid withdrawal' (TSW). After the withdrawal period is over the atopic dermatitis can cease or is less severe than it was before.<ref name="pmid25378953">Template:Cite journal</ref>
  • In children the short term use of steroids by mouth increases the risk of vomiting, behavioral changes, and sleeping problems.<ref name="pmid26768830">Template:Cite journal</ref>
  • Dysphonia: Inhaled corticosteroids are used for treatment of asthma as a standard treatment. This can cause local adverse effects like vocal cord dysfunction.<ref>Template:Cite journal</ref>

BiosynthesisEdit

File:Steroidogenesis.png
Steroidogenesis, including corticosteroid biosynthesis.

The corticosteroids are synthesized from cholesterol within the adrenal cortex.<ref name=NusseySaffron2001 /> Most steroidogenic reactions are catalysed by enzymes of the cytochrome P450 family. They are located within the mitochondria and require adrenodoxin as a cofactor (except 21-hydroxylase and 17α-hydroxylase).Template:Cn

Aldosterone and corticosterone share the first part of their biosynthetic pathway. The last part is mediated either by the aldosterone synthase (for aldosterone) or by the 11β-hydroxylase (for corticosterone). These enzymes are nearly identical (they share 11β-hydroxylation and 18-hydroxylation functions), but aldosterone synthase is also able to perform an 18-oxidation. Moreover, aldosterone synthase is found within the zona glomerulosa at the outer edge of the adrenal cortex; 11β-hydroxylase is found in the zona fasciculata and zona glomerulosa.Template:Cn

ClassificationEdit

By chemical structureEdit

In general, corticosteroids are grouped into four classes, based on chemical structure. Allergic reactions to one member of a class typically indicate an intolerance of all members of the class. This is known as the "Coopman classification".<ref name="isbn1-55009-378-9">Template:Cite book</ref><ref name="pmid2757954">Template:Cite journal</ref>

The highlighted steroids are often used in the screening of allergies to topical steroids.<ref name="Wolverton2001">Template:Cite book</ref>

Group A – Hydrocortisone typeEdit

Hydrocortisone, hydrocortisone acetate, cortisone acetate, tixocortol pivalate, prednisolone, methylprednisolone, and prednisone.

Group B – Acetonides (and related substances)Edit

Amcinonide, budesonide, desonide, fluocinolone acetonide, fluocinonide, halcinonide, triamcinolone acetonide, and Deflazacort (O-isopropylidene derivative)

Group C – Betamethasone typeEdit

Beclometasone, betamethasone, dexamethasone, fluocortolone, halometasone, and mometasone.

Group D – EstersEdit

Group D1 – Halogenated (less labile)Edit

Alclometasone dipropionate, betamethasone dipropionate, betamethasone valerate, clobetasol propionate, clobetasone butyrate, fluprednidene acetate, and mometasone furoate.

Group D2 – Labile prodrug estersEdit

Ciclesonide, cortisone acetate, hydrocortisone aceponate, hydrocortisone acetate, hydrocortisone buteprate, hydrocortisone butyrate, hydrocortisone valerate, prednicarbate, and tixocortol pivalate.

By route of administrationEdit

Topical steroidsEdit

{{#invoke:Labelled list hatnote|labelledList|Main article|Main articles|Main page|Main pages}}

For use topically on the skin, eye, and mucous membranes.

Topical corticosteroids are divided in potency classes I to IV in most countries (A to D in Japan). Seven categories are used in the United States to determine the level of potency of any given topical corticosteroid.

Inhaled steroidsEdit

For nasal mucosa, sinuses, bronchi, and lungs.<ref name="WebMD-Asthma">{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

This group includes:

  • Flunisolide<ref name=mayo>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref>

There also exist certain combination preparations such as Advair Diskus in the United States, containing fluticasone propionate and salmeterol (a long-acting bronchodilator), and Symbicort, containing budesonide and formoterol fumarate dihydrate (another long-acting bronchodilator).<ref name=mayo/> They are both approved for use in children over 12 years old.

Oral formsEdit

Such as prednisone, prednisolone, methylprednisolone, or dexamethasone.<ref name="dermnetnz.org">{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

Systemic formsEdit

Available in injectables for intravenous and parenteral routes.<ref name="dermnetnz.org"/>

HistoryEdit

Introduction of early corticosteroids<ref name="pmid16178782">Template:Cite journal</ref><ref name="pmid13875857">Template:Cite journal</ref><ref name="Conde-Taboada2012">Template:Cite book</ref>
Corticosteroid Introduced
Cortisone 1948
Hydrocortisone 1951
Fludrocortisone acetate 1954<ref name="Publishing2013">Template:Cite book</ref>
Prednisolone 1955
Prednisone 1955<ref name="KimRoh2016">Template:Cite book</ref>
Methylprednisolone 1956
Triamcinolone 1956
Dexamethasone 1958
Betamethasone 1958
Triamcinolone acetonide 1958
Fluorometholone 1959
Deflazacort 1969<ref>Template:Cite journal</ref>

Tadeusz Reichstein, Edward Calvin Kendall, and Philip Showalter Hench were awarded the Nobel Prize for Physiology and Medicine in 1950 for their work on hormones of the adrenal cortex, which culminated in the isolation of cortisone.<ref name="pmid24540604">Template:Cite journal</ref>

Initially hailed as a miracle cure and liberally prescribed during the 1950s, steroid treatment brought about adverse events of such a magnitude that the next major category of anti-inflammatory drugs, the nonsteroidal anti-inflammatory drugs (NSAIDs), was so named in order to demarcate from the opprobrium.<ref name="Buer_2014">Template:Cite journal</ref>

Lewis Sarett of Merck & Co. was the first to synthesize cortisone, using a 36-step process that started with deoxycholic acid, which was extracted from ox bile.<ref>Template:Cite patent</ref> The low efficiency of converting deoxycholic acid into cortisone led to a cost of US$200 per gram in 1947. Russell Marker, at Syntex, discovered a much cheaper and more convenient starting material, diosgenin from wild Mexican yams. His conversion of diosgenin into progesterone by a four-step process now known as Marker degradation was an important step in mass production of all steroidal hormones, including cortisone and chemicals used in hormonal contraception.<ref>Template:Cite journal</ref>

In 1952, D.H. Peterson and H.C. Murray of Upjohn developed a process that used Rhizopus mold to oxidize progesterone into a compound that was readily converted to cortisone.<ref>Template:Cite journal</ref> The ability to cheaply synthesize large quantities of cortisone from the diosgenin in yams resulted in a rapid drop in price to US$6 per gramTemplate:When, falling to $0.46 per gram by 1980. Percy Julian's research also aided progress in the field.<ref>Template:Cite patent</ref> The exact nature of cortisone's anti-inflammatory action remained a mystery for years after, however, until the leukocyte adhesion cascade and the role of phospholipase A2 in the production of prostaglandins and leukotrienes was fully understood in the early 1980s.Template:Citation needed

Corticosteroids were voted Allergen of the Year in 2005 by the American Contact Dermatitis Society.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

See alsoEdit

ReferencesEdit

Template:Reflist

Template:Major Drug Groups Template:Endogenous steroids Template:Navboxes Template:Navboxes Template:Authority control